An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement
Status:
Terminated
Trial end date:
2017-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this observational (a study that follows participants forward in time) study
is to compare the functional improvement of hip joint using Harris hip score between 2
treatment groups (infliximab and conventional therapy) at Week 30 in ankylosing spondylitis
(an autoimmune disease causing chronic inflammation at tendon ends and ligament attachment
points) participants with hip involvement.